A groundbreaking study shows that specialized brain scans can identify the earliest signs of Alzheimer's disease in people with no memory problems or cognitive symptoms, opening new possibilities for early intervention and prevention. Researchers at the Barcelonaβeta Brain Research Center (BBRC) found that tau positron emission tomography (PET) scans, which visualize protein accumulation in the brain, can detect subtle changes that current blood tests cannot yet reliably identify .

How Can Brain Scans Detect Alzheimer's Before Symptoms Appear?

The study involved 99 cognitively unimpaired adults at increased risk for Alzheimer's due to family history or genetic factors. Participants underwent tau PET scans using an advanced tracer called 18F-RO-948, which detects tau protein at lower levels with greater accuracy than earlier imaging methods. The scans revealed that a significant proportion of these otherwise healthy individuals already had measurable tau deposition, a hallmark of Alzheimer's disease, in brain regions typically affected by the condition .

The tau accumulation followed a well-known pattern called the Braak sequence, which describes how tau gradually spreads through the brain. This pattern was previously only observed in postmortem studies, but researchers can now visualize it in living, symptom-free individuals. These findings support the concept that Alzheimer's disease begins silently many years before the first signs of memory loss appear.

"Our findings show that tau PET can detect early tau pathology in cognitively unimpaired individuals at risk for Alzheimer's disease. The limited ability of the fluid biomarkers assessed in this study, including p-tau217, to identify these earliest changes highlights the value of tau PET for studying the earliest biological stages of the disease," said Dr. Mahnaz Shekari, lead author of the study.

Dr. Mahnaz Shekari, Lead Author, Barcelonaβeta Brain Research Center

Why Are Blood Tests Not Yet Sensitive Enough for Early Detection?

The study also examined how well cerebrospinal fluid (CSF) and blood biomarkers reflect the presence of early tau pathology. Among the biomarkers analyzed, p-tau217 showed the strongest association with tau PET signals in both CSF and blood samples. However, when tau pathology was extremely subtle, as it is in many cognitively unimpaired individuals, blood-based biomarkers had limited ability to detect these early changes .

This finding underscores an important distinction: while blood tests are less invasive and more accessible than brain imaging, they may not be sensitive enough to catch Alzheimer's at its earliest stages. Researchers emphasize that early detection will likely require a combination of approaches tailored to the disease stage, rather than relying on a single test.

"In this early stage of the disease, when tau levels are still very low, its accumulation measured by PET scan appears to be more effective at predicting future cognitive decline than amyloid accumulation, whether assessed by PET or fluid biomarkers," explained Dr. Juan Domingo Gispert.

Dr. Juan Domingo Gispert, Researcher, Barcelonaβeta Brain Research Center

What Role Does Your Daily Rhythm Play in Brain Health?

Beyond imaging advances, emerging research reveals that lifestyle factors, particularly your daily rest-activity rhythm, significantly influence brain health and Alzheimer's risk. A new study published in Alzheimer's & Dementia found that older adults with more fragmented circadian rest-activity rhythms experienced greater shrinking of the brain in areas typically affected by Alzheimer's disease .

Researchers analyzed health data from 344 adults with an average age of 73 who had no signs of cognitive impairment. Participants wore wrist accelerometers for up to a week to measure their 24-hour rest-activity patterns, and also had MRI scans of three brain regions affected by Alzheimer's: the parahippocampal gyrus, hippocampus, and amygdala. The results showed that participants with less fragmented daily rhythms had larger brain volumes in memory-associated areas and experienced less shrinkage of the amygdala, which is vital for emotion .

A fragmented rhythm means frequently switching between activity and rest throughout the day, while a less fragmented rhythm involves longer, more sustained periods of activity or rest. The study also found a correlation between more fragmented rest-activity rhythms and quicker expansion of brain ventricles, fluid-filled spaces that enlarge as surrounding brain tissue is lost, suggesting a link between disrupted daily rhythms and more widespread brain atrophy.

How to Maintain a Healthier Rest-Activity Rhythm

• Wake and Sleep Consistency: Wake up at approximately the same time every day and maintain a consistent bedtime to strengthen your circadian rhythm and support brain health.
• Morning Light Exposure: Get bright light exposure in the morning, which helps regulate your natural sleep-wake cycle and promotes daytime alertness.
• Daytime Physical Activity: Stay physically active during the day to maintain energy levels and support brain volume in memory-related regions.
• Meal and Bedtime Timing: Keep meals and bedtime consistent to reinforce your body's internal clock and prevent rhythm fragmentation.
• Limit Extended Naps: Avoid long or late naps that can disrupt your nighttime sleep and fragment your daily activity pattern.
• Avoid Sleep Disruptors: Limit caffeine and alcohol close to bedtime, and discuss with your doctor any sleep disorders like sleep apnea or insomnia that can fragment your rhythm.

What Do Patients Actually Want to Know About Alzheimer's Testing?

Despite advances in blood-based biomarker tests for Alzheimer's, a new survey reveals a significant gap between patient interest and current medical readiness. Northwestern University researchers surveyed nearly 600 primary care patients with an average age of 62 and found that 84% were unfamiliar with Alzheimer's blood tests, and fewer than 2% had previously completed one .

However, after receiving a brief explanation of the tests, 85% of respondents said they would take one if their doctor recommended it. The survey also revealed important insights about what patients value and what concerns them about early detection testing .

"These tests aren't ready for widespread use, but they soon could be. As researchers, we strive for care that centers on the needs of the patient first, so it's important for us to know what they think about those tests," said Andrea Russell, assistant professor of psychology at Northwestern University Feinberg School of Medicine.

Andrea Russell, Assistant Professor of Psychology, Northwestern University Feinberg School of Medicine

When asked about their preferences and concerns regarding Alzheimer's blood tests, patients identified several key factors that would influence their decision to participate in testing:

• Medical Utility: 94% said it was important that test results would inform their medical care and treatment decisions.
• Insurance Coverage: 93% indicated that insurance coverage would be a critical factor in their willingness to undergo testing.
• Education and Support: 88% emphasized the importance of receiving comprehensive education before testing to understand what results mean.
• Convenience: 88% valued easy and convenient access to testing in their primary care settings.
• Cost Concerns: 49% cited cost as a significant barrier, even with insurance coverage.
• Test Reliability: 35% expressed concern about whether the tests are accurate and reliable.
• Fear of Results: 22% worried about receiving a positive result, and 24% feared being treated differently after a positive diagnosis.

Notably, nearly three in four participants said they would expect emotional distress after a positive result. Yet at the same time, about 87% said they would be likely to take steps to improve their brain health if they learned they were at higher risk .

"What's healthy for the brain is healthy for the body. If people learn they may be at higher risk, they may want to take action, such as managing chronic conditions, improving nutrition and staying engaged with their medical care. Those steps could help them prolong independence and well-being," noted Andrea Russell.

Andrea Russell, Assistant Professor of Psychology, Northwestern University Feinberg School of Medicine

The survey also highlighted that 94% of respondents said it was important to offer blood tests to patients with memory or thinking problems, and 60% said it was "very important" to offer testing annually to adults 65 and older, even though such screening is not currently recommended .

These findings underscore a critical opportunity in primary care. Many patients with early cognitive concerns first present to their primary care doctor, where access to specialized testing such as brain scans or spinal taps can be limited. Blood-based biomarker tests offer a less invasive and potentially cheaper alternative, but researchers emphasize that the tests must be paired with proper education, emotional support, and clear pathways to care to be truly effective in helping patients manage their brain health.